Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.

Name: Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.
Author: Dodson, Andrew

Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer. — المؤلف: Dodson, Andrew — Breast cancer research and treatment 20190319

المؤلف: Dodson, Andrew
النشر: Breast cancer research and treatment 20190319
الوصف: 249-258 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Agents, Hormonal؛ Breast؛ Breast Neoplasms؛ Breast Neoplasms, Male؛ Chemotherapy, Adjuvant؛ Female